LACTOBACILLUS SPP: AN INTRODUCTION TO BIOLOGICAL CHARACTERISTICS, DISEASES, EPIDEMIOLOGY, GENOMICS, PATHOGENESIS, IDENTIFICATION AND DETECTION, TREATMENT AND PREVENTION, FUTURE PERSPECTIVE
Introduction:
Lactobacillus spp. are a group of bacteria belonging to the Lactobacillus genus, known for their widespread presence in various ecological niches, including the human body. In this article, we will explore the biological characteristics, diseases associated with Lactobacillus spp., epidemiology, genomics, pathogenesis, methods of identification and detection, treatment and prevention strategies, as well as future perspectives for research and applications.
Biological Characteristics:
Lactobacillus spp. are Gram-positive, non-spore forming, rod-shaped bacteria that are often found in the gastrointestinal tract, oral cavity, and female genital tract. They are characterized by their ability to ferment sugars into lactic acid, contributing to the maintenance of a healthy microbial balance in different environments.
Diseases:
While Lactobacillus spp. are generally considered beneficial and contribute to host health, certain species or strains can be opportunistic pathogens and cause infections. Lactobacillus-associated diseases are relatively rare but can occur in immunocompromised individuals or those with underlying medical conditions. Examples of Lactobacillus-associated diseases include bacteremia, endocarditis, urinary tract infections, and vaginal infections.
Epidemiology:
Lactobacillus spp. have a complex epidemiology, and their presence and prevalence can vary among different populations and geographical regions. Some strains of Lactobacillus spp. are commonly found in fermented foods and probiotic preparations, which can be a potential source of both beneficial and pathogenic strains.
Genomics:
Advancements in genomic sequencing technologies have facilitated the study of Lactobacillus spp. genomes. Comparative genomics and metagenomics approaches have provided insights into the genetic diversity, adaptive capabilities, and potential virulence factors of different Lactobacillus species.
Pathogenesis:
The pathogenesis of Lactobacillus-associated diseases is multifactorial and can involve several mechanisms, including the production of enzymes, adhesins, and toxins, as well as the ability to evade host immune responses. However, it is important to note that pathogenicity is strain-specific, and most Lactobacillus spp. strains are harmless or even beneficial.
Identification and Detection:
Accurate identification and detection of Lactobacillus spp. are essential for diagnosing infections and distinguishing between pathogenic and non-pathogenic strains. Traditional methods, such as culture-based techniques and biochemical tests, as well as molecular methods, including polymerase chain reaction (PCR) and DNA sequencing, are commonly used for species-level identification.
Treatment and Prevention:
The treatment of Lactobacillus-associated infections depends on the severity and site of infection. Antibiotic susceptibility testing is necessary to guide appropriate antimicrobial therapy. In some cases, the removal of foreign bodies or infected devices may be required. Prevention strategies include maintaining good hygiene practices, proper use of probiotic products, and adherence to infection control measures in healthcare settings.
Future Perspective:
Future research on Lactobacillus spp. is expected to focus on a deeper understanding of the mechanisms underlying their beneficial and pathogenic properties. This includes studying the interactions between Lactobacillus spp. and the host immune system, exploring their potential use as therapeutic agents, and developing targeted approaches for the prevention and treatment of Lactobacillus-associated infections.
Keywords: Lactobacillus spp., bacteria, biological characteristics, diseases, epidemiology, genomics, pathogenesis, identification, detection, treatment, prevention, future perspective.
References:
1. Salminen, S., von Wright, A., & Ouwehand, A.
(Eds.). (2004). Lactic acid bacteria: microbiological and functional aspects (Vol. 1). CRC Press.
2. Reid, G., Charbonneau, D., & Erb, J. (2003). Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS immunology and medical microbiology, 35(1), 131-134.
3. Morita, H., Toh, H., & Oshima, K. (2009). Complete genome sequence of the probiotic Lactobacillus rhamnosus ATCC 53103. Journal of bacteriology, 191(24), 7630-7631.
4. Macklaim, J. M., Fernandes, A. D., Di Bella, J. M., Hammond, J. A., Reid, G., & Gloor, G. B. (2013). Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis. Microbiome, 1(1), 12.
5. Shornikova, A. V., Casas, I. A., Isolauri, E., Mykkänen, H., & Vesikari, T. (1997). Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. Journal of Pediatric Gastroenterology and Nutrition, 24(4), 399-404.
DISCLAIMER:
This article is for informational purposes only and should not be considered as medical advice. It is always recommended to consult a healthcare professional for proper diagnosis and treatment options tailored to individual needs.
Thanks
MDMLAB & TEAM
Web : mdmlab.in
0 Comments